microRNA information: hsa-miR-23b-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-23b-3p | miRbase |
Accession: | MIMAT0000418 | miRbase |
Precursor name: | hsa-mir-23b | miRbase |
Precursor accession: | MI0000439 | miRbase |
Symbol: | MIR23B | HGNC |
RefSeq ID: | NR_029664 | GenBank |
Sequence: | AUCACAUUGCCAGGGAUUACC |
Reported expression in cancers: hsa-miR-23b-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-23b-3p | bladder cancer | downregulation | "In this study we show that miRNA-23b miR-23b acts ......" | 23844063 | qPCR |
hsa-miR-23b-3p | breast cancer | upregulation | "Among methods for profiling levels of miRNAs next- ......" | 22387599 | RNA-Seq; qPCR; Northern blot |
hsa-miR-23b-3p | breast cancer | upregulation | "We identified miR-23b and miR-27b as miRNAs that a ......" | 23338610 | |
hsa-miR-23b-3p | breast cancer | upregulation | "miR-23b was found to be up-regulated 56.69 fold fo ......" | 26199568 | |
hsa-miR-23b-3p | cervical and endocervical cancer | downregulation | "miR-23b is often downregulated in HPV-associated c ......" | 21242962 | |
hsa-miR-23b-3p | esophageal cancer | deregulation | "Differentially-expressed miRNAs were analyzed usin ......" | 23534712 | Reverse transcription PCR |
hsa-miR-23b-3p | gastric cancer | upregulation | "Up Regulation of Plasma miR 23b is Associated with ......" | 26835790 | qPCR |
hsa-miR-23b-3p | glioblastoma | deregulation | "Among the down-regulated miRNAs miR-23b has been r ......" | 22745829 | |
hsa-miR-23b-3p | glioblastoma | deregulation | "Hypoxic signature of microRNAs in glioblastoma: in ......" | 25129238 | RNA-Seq |
hsa-miR-23b-3p | kidney renal cell cancer | downregulation | "Conversely decreased expression of miR-106b miR-99 ......" | 26416448 | |
hsa-miR-23b-3p | lung squamous cell cancer | deregulation | "Recently miR-23b has emerged as a promising new ca ......" | 27268921 | |
hsa-miR-23b-3p | lymphoma | upregulation | "However the expression level of miR-23 in radiatio ......" | 24356489 | qPCR |
hsa-miR-23b-3p | ovarian cancer | downregulation | "Furthermore the down-regulation of miR-23b was sig ......" | 24613919 | |
hsa-miR-23b-3p | pancreatic cancer | upregulation | "We identified hsa-miR-21 hsa-miR-23a hsa-miR-23b a ......" | 26121640 | |
hsa-miR-23b-3p | prostate cancer | downregulation | "Five miRNAs miR-23b -100 -145 -221 and -222 were s ......" | 18949015 | Microarray; qPCR |
hsa-miR-23b-3p | prostate cancer | downregulation | "The expression of miR-23b and miR-27b which are en ......" | 23300597 | |
hsa-miR-23b-3p | prostate cancer | downregulation | "Genes involved in these pathways were analyzed wit ......" | 25604141 | |
hsa-miR-23b-3p | prostate cancer | downregulation | "miR-23b and -27b encoded in the same miR cluster m ......" | 26898757 |
Reported cancer pathway affected by hsa-miR-23b-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-23b-3p | bladder cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA 23b functions as a tumor suppressor by re ......" | 23844063 | Colony formation; Luciferase |
hsa-miR-23b-3p | ovarian cancer | cell cycle pathway | "The cell inhibition rates after the treatments wer ......" | 25613625 | Flow cytometry; MTT assay; Western blot |
hsa-miR-23b-3p | ovarian cancer | Apoptosis pathway | "MiR 23b targets cyclin G1 and suppresses ovarian c ......" | 26872615 | Luciferase |
hsa-miR-23b-3p | prostate cancer | cell cycle pathway; Apoptosis pathway | "miR 23b represses proto oncogene Src kinase and fu ......" | 23074286 | Colony formation; RNAi |
Reported cancer prognosis affected by hsa-miR-23b-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-23b-3p | bladder cancer | malignant trasformation; poor survival; cell migration | "MicroRNA 23b functions as a tumor suppressor by re ......" | 23844063 | Colony formation; Luciferase |
hsa-miR-23b-3p | bladder cancer | staging | "Deregulation of seven CpG island harboring miRNAs ......" | 27064870 | |
hsa-miR-23b-3p | breast cancer | motility | "Among various microRNAs miRNAs increased in BM-MSC ......" | 24985346 | |
hsa-miR-23b-3p | breast cancer | drug resistance | "Genistein induced mir 23b expression inhibits the ......" | 26199568 | |
hsa-miR-23b-3p | cervical and endocervical cancer | progression; staging; malignant trasformation | "miR 23b as a potential tumor suppressor and its re ......" | 26622315 | |
hsa-miR-23b-3p | colorectal cancer | worse prognosis | "Three miRNAs including hsa-mir-23b hsa-mir-365-1 a ......" | 26269151 | |
hsa-miR-23b-3p | gastric cancer | worse prognosis; staging; metastasis; progression | "To investigate the clinical significance of microR ......" | 25674252 | |
hsa-miR-23b-3p | gastric cancer | drug resistance; poor survival | "miR 23b 3p regulates the chemoresistance of gastri ......" | 25996293 | Western blot |
hsa-miR-23b-3p | gastric cancer | worse prognosis; poor survival; staging; metastasis; differentiation | "Up Regulation of Plasma miR 23b is Associated with ......" | 26835790 | |
hsa-miR-23b-3p | glioblastoma | cell migration | "miRNA expression profiling in migrating glioblasto ......" | 22745829 | |
hsa-miR-23b-3p | kidney renal cell cancer | worse prognosis | "Conversely decreased expression of miR-106b miR-99 ......" | 26416448 | |
hsa-miR-23b-3p | liver cancer | cell migration | "MicroRNA 23b mediates urokinase and c met downmodu ......" | 19490101 | Luciferase |
hsa-miR-23b-3p | lung squamous cell cancer | poor survival; recurrence; staging | "An integrated genome wide approach to discover der ......" | 26314549 | |
hsa-miR-23b-3p | lung squamous cell cancer | progression; poor survival | "Prognostic significance of miR 23b in combination ......" | 27268921 | |
hsa-miR-23b-3p | lymphoma | tumorigenesis | "However the expression level of miR-23 in radiatio ......" | 24356489 | Luciferase |
hsa-miR-23b-3p | ovarian cancer | progression; worse prognosis | "MicroRNA 23b is an independent prognostic marker a ......" | 24613919 | |
hsa-miR-23b-3p | ovarian cancer | progression; tumorigenesis | "MiR 23b targets cyclin G1 and suppresses ovarian c ......" | 26872615 | Luciferase |
hsa-miR-23b-3p | pancreatic cancer | drug resistance | "MicroRNA 23b regulates autophagy associated with r ......" | 23916944 | Luciferase |
hsa-miR-23b-3p | prostate cancer | malignant trasformation | "Five miRNAs miR-23b -100 -145 -221 and -222 were s ......" | 18949015 | |
hsa-miR-23b-3p | prostate cancer | drug resistance | "However the expression of miR-23b -27b -15a and -1 ......" | 22127852 | |
hsa-miR-23b-3p | prostate cancer | progression; drug resistance | "MicroRNA 23b downregulates peroxiredoxin III in hu ......" | 22710126 | |
hsa-miR-23b-3p | prostate cancer | poor survival; recurrence | "miR 23b represses proto oncogene Src kinase and fu ......" | 23074286 | Colony formation; RNAi |
hsa-miR-23b-3p | prostate cancer | progression; poor survival | "The expression of miR-23b and miR-27b which are en ......" | 23300597 | Colony formation |
Reported gene related to hsa-miR-23b-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-23b-3p | gastric cancer | ATG12 | "miR 23b 3p regulates the chemoresistance of gastri ......" | 25996293 |
hsa-miR-23b-3p | pancreatic cancer | ATG12 | "MIR23B targets the 3?UTR of the autophagy-related ......" | 24145177 |
hsa-miR-23b-3p | pancreatic cancer | ATG12 | "The target of miR-23b ATG12 was overexpressed in r ......" | 23916944 |
hsa-miR-23b-3p | cervical and endocervical cancer | PLAU | "Thus the importance of miR-23b and uPA in HPV-asso ......" | 21242962 |
hsa-miR-23b-3p | liver cancer | PLAU | "In the present study to understand whether the exp ......" | 19490101 |
hsa-miR-23b-3p | acute myeloid leukemia | PRDX3 | "MicroRNA 26a 5p and microRNA 23b 3p up regulate pe ......" | 24828865 |
hsa-miR-23b-3p | prostate cancer | PRDX3 | "MicroRNA 23b downregulates peroxiredoxin III in hu ......" | 22710126 |
hsa-miR-23b-3p | lung squamous cell cancer | ABCB1 | "Prognostic significance of miR 23b in combination ......" | 27268921 |
hsa-miR-23b-3p | ovarian cancer | CCNG1 | "MiR 23b targets cyclin G1 and suppresses ovarian c ......" | 26872615 |
hsa-miR-23b-3p | breast cancer | EGF | "Prooncogenic factors miR 23b and miR 27b are regul ......" | 23338610 |
hsa-miR-23b-3p | lymphoma | FAS | "Moreover over-expression of Fas rescued the pro-pr ......" | 24356489 |
hsa-miR-23b-3p | thyroid cancer | FLNA | "Kaplan-Meier and multivariate analysis showed a si ......" | 24443580 |
hsa-miR-23b-3p | gastric cancer | HMGB2 | "miR 23b 3p regulates the chemoresistance of gastri ......" | 25996293 |
hsa-miR-23b-3p | ovarian cancer | HNF1B | "MicroRNA 23b is an independent prognostic marker a ......" | 24613919 |
hsa-miR-23b-3p | breast cancer | MARCKS | "Among various microRNAs miRNAs increased in BM-MSC ......" | 24985346 |
hsa-miR-23b-3p | liver cancer | MET | "MicroRNA 23b mediates urokinase and c met downmodu ......" | 19490101 |
hsa-miR-23b-3p | breast cancer | NISCH | "Nischarin NISCH expression was augmented by knockd ......" | 23338610 |
hsa-miR-23b-3p | ovarian cancer | PCNA | "MiR 23b targets cyclin G1 and suppresses ovarian c ......" | 26872615 |
hsa-miR-23b-3p | glioblastoma | PTK2 | "Increased expression of miR-23b reduced the protei ......" | 22745829 |
hsa-miR-23b-3p | glioblastoma | PTK2B | "miRNA expression profiling in migrating glioblasto ......" | 22745829 |
hsa-miR-23b-3p | ovarian cancer | RUNX2 | "Then ectopic expression of miR-23b significantly i ......" | 24613919 |
hsa-miR-23b-3p | prostate cancer | SRC | "miR 23b represses proto oncogene Src kinase and fu ......" | 23074286 |
hsa-miR-23b-3p | breast cancer | TNF | "Prooncogenic factors miR 23b and miR 27b are regul ......" | 23338610 |
hsa-miR-23b-3p | cervical and endocervical cancer | TP53 | "A consensus p53 binding site is detected in the pr ......" | 21242962 |
hsa-miR-23b-3p | gastric cancer | TUSC7 | "Reciprocal repression between TUSC7 and miR 23b in ......" | 25765901 |
hsa-miR-23b-3p | bladder cancer | ZEB1 | "MicroRNA 23b functions as a tumor suppressor by re ......" | 23844063 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-23b-3p | ABCF1 | 10 cancers: BLCA; CESC; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.115; TCGA CESC -0.08; TCGA ESCA -0.131; TCGA HNSC -0.066; TCGA LGG -0.12; TCGA LUAD -0.102; TCGA PAAD -0.163; TCGA PRAD -0.064; TCGA THCA -0.103; TCGA UCEC -0.079 |
hsa-miR-23b-3p | CCNB2 | 13 cancers: BLCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.355; TCGA COAD -0.33; TCGA KIRC -0.938; TCGA KIRP -0.42; TCGA LGG -0.198; TCGA LIHC -0.642; TCGA LUAD -0.601; TCGA LUSC -0.305; TCGA PAAD -0.653; TCGA PRAD -0.638; TCGA THCA -0.321; TCGA STAD -0.52; TCGA UCEC -0.506 |
hsa-miR-23b-3p | CCT7 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.079; TCGA CESC -0.114; TCGA COAD -0.202; TCGA HNSC -0.141; TCGA KIRC -0.069; TCGA KIRP -0.177; TCGA LGG -0.144; TCGA LUAD -0.157; TCGA PRAD -0.194; TCGA STAD -0.131 |
hsa-miR-23b-3p | CDC20 | 13 cancers: BLCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.445; TCGA CESC -0.145; TCGA COAD -0.323; TCGA HNSC -0.264; TCGA KIRC -0.727; TCGA LIHC -0.728; TCGA LUAD -0.664; TCGA LUSC -0.488; TCGA PAAD -0.659; TCGA PRAD -0.787; TCGA THCA -0.409; TCGA STAD -0.657; TCGA UCEC -0.487 |
hsa-miR-23b-3p | CDCA8 | 12 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.3; TCGA COAD -0.277; TCGA ESCA -0.311; TCGA KIRC -0.652; TCGA KIRP -0.263; TCGA LIHC -0.47; TCGA LUAD -0.526; TCGA LUSC -0.308; TCGA PRAD -0.628; TCGA THCA -0.271; TCGA STAD -0.636; TCGA UCEC -0.393 |
hsa-miR-23b-3p | DDX47 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; OV; PAAD; STAD | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.08; TCGA CESC -0.09; TCGA COAD -0.188; TCGA HNSC -0.068; TCGA KIRC -0.137; TCGA KIRP -0.093; TCGA LUAD -0.158; TCGA OV -0.105; TCGA PAAD -0.155; TCGA STAD -0.188 |
hsa-miR-23b-3p | DONSON | 9 cancers: BLCA; COAD; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.207; TCGA COAD -0.201; TCGA KIRC -0.463; TCGA KIRP -0.219; TCGA LGG -0.118; TCGA LUAD -0.32; TCGA LUSC -0.238; TCGA PRAD -0.215; TCGA UCEC -0.132 |
hsa-miR-23b-3p | E2F1 | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.373; TCGA BRCA -0.125; TCGA COAD -0.28; TCGA KIRC -0.781; TCGA KIRP -0.62; TCGA LIHC -0.508; TCGA LUAD -0.546; TCGA LUSC -0.259; TCGA PAAD -0.448; TCGA PRAD -0.478; TCGA STAD -0.452; TCGA UCEC -0.407 |
hsa-miR-23b-3p | EIF4A1 | 15 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.122; TCGA COAD -0.163; TCGA HNSC -0.244; TCGA KIRC -0.201; TCGA KIRP -0.235; TCGA LGG -0.152; TCGA LIHC -0.134; TCGA LUAD -0.127; TCGA OV -0.09; TCGA PAAD -0.304; TCGA PRAD -0.299; TCGA SARC -0.184; TCGA THCA -0.143; TCGA STAD -0.168; TCGA UCEC -0.091 |
hsa-miR-23b-3p | GAPDH | 10 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.193; TCGA COAD -0.239; TCGA HNSC -0.128; TCGA KIRC -0.558; TCGA KIRP -0.318; TCGA LIHC -0.285; TCGA LUAD -0.253; TCGA PRAD -0.218; TCGA STAD -0.268; TCGA UCEC -0.19 |
hsa-miR-23b-3p | ITPR3 | 9 cancers: BLCA; CESC; KIRC; KIRP; LIHC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.193; TCGA CESC -0.243; TCGA KIRC -0.282; TCGA KIRP -0.336; TCGA LIHC -0.873; TCGA SARC -0.162; TCGA THCA -0.16; TCGA STAD -0.287; TCGA UCEC -0.164 |
hsa-miR-23b-3p | LASP1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.107; TCGA BRCA -0.087; TCGA CESC -0.217; TCGA ESCA -0.398; TCGA HNSC -0.092; TCGA KIRP -0.119; TCGA LGG -0.055; TCGA LIHC -0.135; TCGA LUSC -0.08; TCGA SARC -0.134; TCGA STAD -0.216 |
hsa-miR-23b-3p | LBR | 10 cancers: BLCA; CESC; COAD; ESCA; LGG; LUAD; OV; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BLCA -0.224; TCGA CESC -0.177; TCGA COAD -0.232; TCGA ESCA -0.28; TCGA LGG -0.157; TCGA LUAD -0.142; TCGA OV -0.267; TCGA THCA -0.338; TCGA STAD -0.18; TCGA UCEC -0.135 |
hsa-miR-23b-3p | PSMD14 | 12 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.164; TCGA COAD -0.254; TCGA HNSC -0.088; TCGA KIRC -0.156; TCGA KIRP -0.214; TCGA LIHC -0.2; TCGA LUAD -0.156; TCGA OV -0.067; TCGA PRAD -0.175; TCGA SARC -0.063; TCGA STAD -0.23; TCGA UCEC -0.178 |
hsa-miR-23b-3p | RAD51 | 10 cancers: BLCA; COAD; KIRC; KIRP; LIHC; LUAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.18; TCGA COAD -0.275; TCGA KIRC -0.547; TCGA KIRP -0.428; TCGA LIHC -0.457; TCGA LUAD -0.549; TCGA PRAD -0.534; TCGA THCA -0.32; TCGA STAD -0.496; TCGA UCEC -0.369 |
hsa-miR-23b-3p | RPN2 | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.089; TCGA CESC -0.196; TCGA ESCA -0.304; TCGA HNSC -0.11; TCGA KIRC -0.191; TCGA KIRP -0.139; TCGA LIHC -0.15; TCGA LUAD -0.122; TCGA LUSC -0.152; TCGA OV -0.104; TCGA PRAD -0.124; TCGA SARC -0.125; TCGA STAD -0.177; TCGA UCEC -0.216 |
hsa-miR-23b-3p | SLC16A1 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; OV; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.571; TCGA COAD -0.416; TCGA HNSC -0.293; TCGA KIRC -0.523; TCGA KIRP -0.351; TCGA LUAD -0.416; TCGA OV -0.133; TCGA PRAD -0.281; TCGA THCA -0.269 |
hsa-miR-23b-3p | SNRPC | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.159; TCGA BRCA -0.069; TCGA COAD -0.28; TCGA HNSC -0.232; TCGA KIRC -0.099; TCGA KIRP -0.154; TCGA LUAD -0.139; TCGA LUSC -0.196; TCGA OV -0.131; TCGA PAAD -0.198; TCGA PRAD -0.223; TCGA SARC -0.086; TCGA STAD -0.249; TCGA UCEC -0.107 |
hsa-miR-23b-3p | TCP1 | 11 cancers: BLCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; OV; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.071; TCGA CESC -0.095; TCGA COAD -0.254; TCGA HNSC -0.079; TCGA LGG -0.068; TCGA LIHC -0.094; TCGA LUAD -0.135; TCGA OV -0.109; TCGA PRAD -0.311; TCGA STAD -0.142; TCGA UCEC -0.111 |
hsa-miR-23b-3p | XPO1 | 10 cancers: BLCA; CESC; COAD; KIRC; LIHC; LUAD; OV; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.117; TCGA CESC -0.096; TCGA COAD -0.171; TCGA KIRC -0.083; TCGA LIHC -0.082; TCGA LUAD -0.188; TCGA OV -0.057; TCGA PRAD -0.084; TCGA STAD -0.141; TCGA UCEC -0.094 |
hsa-miR-23b-3p | CCDC34 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; OV; PRAD; STAD | MirTarget | TCGA BLCA -0.154; TCGA BRCA -0.062; TCGA COAD -0.157; TCGA ESCA -0.305; TCGA KIRC -0.296; TCGA LUAD -0.26; TCGA OV -0.117; TCGA PRAD -0.2; TCGA STAD -0.379 |
hsa-miR-23b-3p | PDIA6 | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.24; TCGA CESC -0.349; TCGA ESCA -0.216; TCGA HNSC -0.169; TCGA KIRC -0.191; TCGA KIRP -0.174; TCGA LIHC -0.139; TCGA LUAD -0.145; TCGA LUSC -0.18; TCGA OV -0.165; TCGA PRAD -0.168; TCGA STAD -0.2; TCGA UCEC -0.234 |
hsa-miR-23b-3p | UBA6 | 9 cancers: BLCA; COAD; KIRC; LIHC; LUAD; PRAD; THCA; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.14; TCGA COAD -0.186; TCGA KIRC -0.221; TCGA LIHC -0.085; TCGA LUAD -0.22; TCGA PRAD -0.102; TCGA THCA -0.091; TCGA STAD -0.175; TCGA UCEC -0.098 |
hsa-miR-23b-3p | GOLM1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.177; TCGA BRCA -0.103; TCGA CESC -0.65; TCGA ESCA -1.062; TCGA HNSC -0.129; TCGA LIHC -0.73; TCGA LUSC -0.189; TCGA PRAD -0.498; TCGA SARC -0.182; TCGA THCA -0.175; TCGA STAD -0.32 |
hsa-miR-23b-3p | SSR3 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PRAD; STAD | MirTarget | TCGA BLCA -0.091; TCGA CESC -0.204; TCGA ESCA -0.153; TCGA HNSC -0.225; TCGA KIRC -0.204; TCGA KIRP -0.21; TCGA LIHC -0.141; TCGA LUAD -0.18; TCGA OV -0.069; TCGA PRAD -0.151; TCGA STAD -0.22 |
hsa-miR-23b-3p | RAD51AP1 | 11 cancers: BLCA; COAD; KIRC; KIRP; LIHC; LUAD; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.396; TCGA COAD -0.378; TCGA KIRC -0.585; TCGA KIRP -0.302; TCGA LIHC -0.276; TCGA LUAD -0.568; TCGA OV -0.198; TCGA PRAD -0.403; TCGA THCA -0.21; TCGA STAD -0.624; TCGA UCEC -0.433 |
hsa-miR-23b-3p | TFAM | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.142; TCGA CESC -0.177; TCGA COAD -0.24; TCGA ESCA -0.249; TCGA HNSC -0.067; TCGA LGG -0.115; TCGA LUAD -0.135; TCGA LUSC -0.124; TCGA OV -0.085; TCGA PRAD -0.146; TCGA STAD -0.24; TCGA UCEC -0.189 |
hsa-miR-23b-3p | MT2A | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.708; TCGA BRCA -0.135; TCGA CESC -0.294; TCGA HNSC -1.032; TCGA KIRC -0.609; TCGA KIRP -0.319; TCGA LUAD -0.252; TCGA LUSC -0.676; TCGA PAAD -0.777; TCGA SARC -0.362; TCGA THCA -0.47 |
hsa-miR-23b-3p | HMGN2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.161; TCGA BRCA -0.082; TCGA COAD -0.164; TCGA HNSC -0.115; TCGA LUAD -0.133; TCGA LUSC -0.125; TCGA OV -0.104; TCGA PRAD -0.193; TCGA STAD -0.187; TCGA UCEC -0.125 |
hsa-miR-23b-3p | SFXN5 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.121; TCGA BRCA -0.385; TCGA CESC -0.118; TCGA HNSC -0.149; TCGA KIRP -0.154; TCGA LUAD -0.276; TCGA LUSC -0.257; TCGA STAD -0.317; TCGA UCEC -0.098 |
hsa-miR-23b-3p | DEPDC1 | 11 cancers: BLCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.39; TCGA COAD -0.296; TCGA KIRC -0.88; TCGA KIRP -0.332; TCGA LIHC -0.623; TCGA LUAD -0.72; TCGA LUSC -0.378; TCGA PRAD -0.364; TCGA THCA -0.408; TCGA STAD -0.589; TCGA UCEC -0.556 |
hsa-miR-23b-3p | IL18 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.258; TCGA HNSC -0.291; TCGA KIRC -0.313; TCGA KIRP -0.512; TCGA LIHC -0.615; TCGA PAAD -0.405; TCGA SARC -0.576; TCGA THCA -0.568; TCGA STAD -0.369 |
hsa-miR-23b-3p | GPR180 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.227; TCGA CESC -0.143; TCGA ESCA -0.252; TCGA HNSC -0.141; TCGA KIRC -0.116; TCGA LUAD -0.116; TCGA LUSC -0.105; TCGA OV -0.142; TCGA PRAD -0.096; TCGA THCA -0.073; TCGA UCEC -0.156 |
hsa-miR-23b-3p | CHST11 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD | MirTarget | TCGA BLCA -0.639; TCGA HNSC -0.568; TCGA KIRC -0.664; TCGA KIRP -0.499; TCGA LGG -0.136; TCGA LIHC -0.542; TCGA LUAD -0.275; TCGA LUSC -0.265; TCGA PAAD -0.639 |
hsa-miR-23b-3p | ISCA2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.146; TCGA BRCA -0.14; TCGA CESC -0.09; TCGA COAD -0.269; TCGA HNSC -0.206; TCGA KIRP -0.137; TCGA LGG -0.055; TCGA LUSC -0.201; TCGA OV -0.147; TCGA PRAD -0.119; TCGA SARC -0.225; TCGA STAD -0.218; TCGA UCEC -0.107 |
hsa-miR-23b-3p | MAGOHB | 16 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.2; TCGA BRCA -0.056; TCGA COAD -0.275; TCGA HNSC -0.194; TCGA KIRC -0.358; TCGA KIRP -0.155; TCGA LGG -0.168; TCGA LIHC -0.106; TCGA LUAD -0.225; TCGA LUSC -0.121; TCGA OV -0.2; TCGA PAAD -0.324; TCGA PRAD -0.232; TCGA THCA -0.055; TCGA STAD -0.272; TCGA UCEC -0.17 |
hsa-miR-23b-3p | CCL7 | 9 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.721; TCGA CESC -0.509; TCGA ESCA -0.53; TCGA HNSC -0.586; TCGA LUAD -0.461; TCGA LUSC -0.354; TCGA PAAD -1.067; TCGA STAD -0.704; TCGA UCEC -0.446 |
hsa-miR-23b-3p | PITPNC1 | 10 cancers: BLCA; CESC; HNSC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.126; TCGA CESC -0.222; TCGA HNSC -0.09; TCGA LUAD -0.163; TCGA LUSC -0.208; TCGA OV -0.187; TCGA PAAD -0.413; TCGA SARC -0.292; TCGA THCA -0.187; TCGA UCEC -0.112 |
hsa-miR-23b-3p | DCUN1D5 | 14 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; OV; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.175; TCGA CESC -0.194; TCGA COAD -0.313; TCGA HNSC -0.314; TCGA KIRC -0.215; TCGA KIRP -0.198; TCGA LGG -0.089; TCGA LIHC -0.141; TCGA LUAD -0.172; TCGA OV -0.111; TCGA PAAD -0.345; TCGA PRAD -0.363; TCGA THCA -0.087; TCGA UCEC -0.131 |
hsa-miR-23b-3p | GCNT1 | 9 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LIHC; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.462; TCGA CESC -0.385; TCGA ESCA -1.024; TCGA KIRC -0.353; TCGA KIRP -0.465; TCGA LIHC -0.335; TCGA PRAD -0.361; TCGA SARC -0.439; TCGA THCA -0.119 |
hsa-miR-23b-3p | NEK6 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUSC; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.259; TCGA CESC -0.458; TCGA ESCA -0.486; TCGA HNSC -0.271; TCGA KIRC -0.337; TCGA LUSC -0.206; TCGA SARC -0.232; TCGA THCA -0.811; TCGA STAD -0.281; TCGA UCEC -0.154 |
hsa-miR-23b-3p | SMS | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.278; TCGA CESC -0.257; TCGA COAD -0.171; TCGA ESCA -0.214; TCGA HNSC -0.303; TCGA KIRP -0.151; TCGA LIHC -0.14; TCGA LUAD -0.237; TCGA PRAD -0.47; TCGA STAD -0.155; TCGA UCEC -0.209 |
hsa-miR-23b-3p | ATG12 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; THCA; UCEC | MirTarget | TCGA BLCA -0.084; TCGA COAD -0.137; TCGA ESCA -0.156; TCGA HNSC -0.111; TCGA KIRC -0.305; TCGA KIRP -0.071; TCGA LGG -0.077; TCGA LIHC -0.065; TCGA LUAD -0.066; TCGA LUSC -0.118; TCGA THCA -0.1; TCGA UCEC -0.078 |
hsa-miR-23b-3p | MAPRE1 | 9 cancers: BLCA; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; OV; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.079; TCGA ESCA -0.141; TCGA KIRP -0.131; TCGA LGG -0.117; TCGA LIHC -0.164; TCGA LUAD -0.134; TCGA LUSC -0.113; TCGA OV -0.07; TCGA UCEC -0.096 |
hsa-miR-23b-3p | ADAMTS6 | 9 cancers: BLCA; CESC; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; THCA | MirTarget; miRNATAP | TCGA BLCA -0.42; TCGA CESC -0.324; TCGA ESCA -0.312; TCGA HNSC -0.637; TCGA LGG -0.497; TCGA LIHC -0.491; TCGA LUSC -0.503; TCGA PAAD -0.414; TCGA THCA -0.336 |
hsa-miR-23b-3p | CCM2 | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.239; TCGA BRCA -0.136; TCGA HNSC -0.359; TCGA KIRC -0.409; TCGA KIRP -0.209; TCGA LUAD -0.118; TCGA LUSC -0.275; TCGA PAAD -0.448; TCGA PRAD -0.082; TCGA SARC -0.175; TCGA THCA -0.192; TCGA STAD -0.103 |
hsa-miR-23b-3p | TXNRD1 | 10 cancers: BLCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; OV; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.197; TCGA CESC -0.154; TCGA COAD -0.175; TCGA KIRC -0.155; TCGA KIRP -0.708; TCGA LIHC -0.286; TCGA LUAD -0.54; TCGA OV -0.065; TCGA THCA -0.165; TCGA STAD -0.153 |
hsa-miR-23b-3p | STK4 | 10 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LUSC; OV; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.077; TCGA CESC -0.116; TCGA ESCA -0.345; TCGA KIRC -0.26; TCGA KIRP -0.129; TCGA LUSC -0.148; TCGA OV -0.071; TCGA SARC -0.073; TCGA THCA -0.237; TCGA STAD -0.13 |
hsa-miR-23b-3p | FUT4 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.168; TCGA CESC -0.464; TCGA COAD -0.383; TCGA ESCA -1.206; TCGA KIRC -0.246; TCGA LIHC -0.225; TCGA SARC -0.111; TCGA THCA -0.232; TCGA STAD -0.394 |
hsa-miR-23b-3p | OLA1 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.072; TCGA CESC -0.109; TCGA COAD -0.195; TCGA HNSC -0.068; TCGA KIRC -0.077; TCGA KIRP -0.158; TCGA LIHC -0.108; TCGA LUAD -0.11; TCGA OV -0.17; TCGA PRAD -0.266; TCGA STAD -0.173; TCGA UCEC -0.107 |
hsa-miR-23b-3p | DCBLD2 | 9 cancers: BLCA; CESC; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.368; TCGA CESC -0.17; TCGA HNSC -0.339; TCGA KIRC -0.286; TCGA LUAD -0.22; TCGA LUSC -0.198; TCGA PAAD -0.514; TCGA SARC -0.132; TCGA THCA -0.12 |
hsa-miR-23b-3p | DERL2 | 14 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.098; TCGA BRCA -0.059; TCGA ESCA -0.107; TCGA HNSC -0.174; TCGA KIRC -0.129; TCGA KIRP -0.141; TCGA LUAD -0.09; TCGA LUSC -0.136; TCGA OV -0.119; TCGA PAAD -0.221; TCGA PRAD -0.146; TCGA SARC -0.124; TCGA STAD -0.183; TCGA UCEC -0.119 |
hsa-miR-23b-3p | KPNB1 | 9 cancers: BLCA; CESC; COAD; LIHC; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.132; TCGA CESC -0.091; TCGA COAD -0.201; TCGA LIHC -0.113; TCGA LUAD -0.223; TCGA PRAD -0.208; TCGA THCA -0.073; TCGA STAD -0.108; TCGA UCEC -0.106 |
hsa-miR-23b-3p | HNRNPA2B1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUSC; OV; PRAD; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.086; TCGA COAD -0.147; TCGA ESCA -0.097; TCGA HNSC -0.074; TCGA LGG -0.072; TCGA LUSC -0.139; TCGA OV -0.079; TCGA PRAD -0.244; TCGA STAD -0.232; TCGA UCEC -0.072 |
hsa-miR-23b-3p | CALU | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; THCA | mirMAP | TCGA BLCA -0.162; TCGA CESC -0.212; TCGA ESCA -0.147; TCGA HNSC -0.177; TCGA KIRC -0.341; TCGA KIRP -0.173; TCGA LIHC -0.178; TCGA LUAD -0.111; TCGA THCA -0.118 |
hsa-miR-23b-3p | RBM17 | 10 cancers: BLCA; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.165; TCGA HNSC -0.085; TCGA KIRC -0.089; TCGA LGG -0.084; TCGA LIHC -0.058; TCGA LUAD -0.134; TCGA PAAD -0.122; TCGA PRAD -0.097; TCGA STAD -0.125; TCGA UCEC -0.065 |
hsa-miR-23b-3p | HMGA2 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUSC; OV; PAAD; SARC | mirMAP | TCGA BLCA -0.866; TCGA CESC -0.673; TCGA ESCA -0.7; TCGA HNSC -1.065; TCGA KIRC -0.606; TCGA LUSC -0.591; TCGA OV -0.739; TCGA PAAD -0.832; TCGA SARC -0.801 |
hsa-miR-23b-3p | BRI3BP | 10 cancers: BLCA; BRCA; CESC; ESCA; LIHC; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.203; TCGA BRCA -0.091; TCGA CESC -0.135; TCGA ESCA -0.212; TCGA LIHC -0.23; TCGA LUAD -0.27; TCGA PRAD -0.232; TCGA THCA -0.324; TCGA STAD -0.449; TCGA UCEC -0.354 |
hsa-miR-23b-3p | ARHGAP11A | 10 cancers: BLCA; COAD; ESCA; KIRC; LIHC; LUAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.295; TCGA COAD -0.255; TCGA ESCA -0.285; TCGA KIRC -0.512; TCGA LIHC -0.456; TCGA LUAD -0.517; TCGA PRAD -0.353; TCGA THCA -0.173; TCGA STAD -0.498; TCGA UCEC -0.322 |
hsa-miR-23b-3p | C5orf15 | 11 cancers: BLCA; CESC; ESCA; HNSC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.094; TCGA CESC -0.091; TCGA ESCA -0.236; TCGA HNSC -0.094; TCGA LUSC -0.124; TCGA OV -0.068; TCGA PRAD -0.159; TCGA SARC -0.191; TCGA THCA -0.052; TCGA STAD -0.292; TCGA UCEC -0.115 |
hsa-miR-23b-3p | TPM3 | 17 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.208; TCGA CESC -0.116; TCGA COAD -0.107; TCGA ESCA -0.248; TCGA HNSC -0.125; TCGA KIRC -0.127; TCGA KIRP -0.12; TCGA LIHC -0.179; TCGA LUAD -0.114; TCGA LUSC -0.125; TCGA OV -0.064; TCGA PAAD -0.183; TCGA PRAD -0.08; TCGA SARC -0.248; TCGA THCA -0.112; TCGA STAD -0.311; TCGA UCEC -0.203 |
hsa-miR-23b-3p | HLA-C | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; PAAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.343; TCGA BRCA -0.173; TCGA CESC -0.405; TCGA ESCA -0.382; TCGA HNSC -0.332; TCGA KIRC -0.202; TCGA KIRP -0.221; TCGA LIHC -0.279; TCGA PAAD -0.36; TCGA SARC -0.298; TCGA THCA -0.463; TCGA STAD -0.444; TCGA UCEC -0.211 |
hsa-miR-23b-3p | MRPL17 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.175; TCGA BRCA -0.143; TCGA COAD -0.17; TCGA HNSC -0.23; TCGA KIRC -0.269; TCGA KIRP -0.324; TCGA LGG -0.052; TCGA LUAD -0.117; TCGA LUSC -0.163; TCGA PAAD -0.163; TCGA PRAD -0.298; TCGA SARC -0.108; TCGA STAD -0.175; TCGA UCEC -0.086 |
hsa-miR-23b-3p | HLA-A | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; PAAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.435; TCGA BRCA -0.144; TCGA CESC -0.264; TCGA ESCA -0.32; TCGA HNSC -0.343; TCGA KIRC -0.286; TCGA KIRP -0.307; TCGA LIHC -0.289; TCGA PAAD -0.377; TCGA SARC -0.275; TCGA THCA -0.44; TCGA STAD -0.308 |
hsa-miR-23b-3p | EIF4A3 | 9 cancers: BLCA; COAD; KIRP; LGG; LUAD; PAAD; PRAD; STAD; UCEC | RAID | TCGA BLCA -0.088; TCGA COAD -0.248; TCGA KIRP -0.115; TCGA LGG -0.106; TCGA LUAD -0.167; TCGA PAAD -0.131; TCGA PRAD -0.175; TCGA STAD -0.19; TCGA UCEC -0.089 |
hsa-miR-23b-3p | BCL2L1 | 9 cancers: BRCA; CESC; ESCA; KIRP; LUSC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.092; TCGA CESC -0.114; TCGA ESCA -0.389; TCGA KIRP -0.235; TCGA LUSC -0.175; TCGA PRAD -0.091; TCGA SARC -0.145; TCGA THCA -0.25; TCGA STAD -0.275 |
hsa-miR-23b-3p | BCS1L | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD | miRNAWalker2 validate | TCGA BRCA -0.138; TCGA COAD -0.189; TCGA HNSC -0.101; TCGA KIRC -0.138; TCGA KIRP -0.189; TCGA LGG -0.131; TCGA LUAD -0.098; TCGA LUSC -0.161; TCGA PRAD -0.269 |
hsa-miR-23b-3p | E2F4 | 13 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.069; TCGA COAD -0.168; TCGA HNSC -0.175; TCGA KIRC -0.175; TCGA KIRP -0.247; TCGA LIHC -0.134; TCGA LUAD -0.138; TCGA LUSC -0.119; TCGA OV -0.067; TCGA PAAD -0.171; TCGA SARC -0.123; TCGA THCA -0.066; TCGA STAD -0.145 |
hsa-miR-23b-3p | EWSR1 | 9 cancers: BRCA; COAD; HNSC; LGG; LUSC; PAAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BRCA -0.118; TCGA COAD -0.125; TCGA HNSC -0.114; TCGA LGG -0.074; TCGA LUSC -0.098; TCGA PAAD -0.137; TCGA PRAD -0.12; TCGA SARC -0.061; TCGA STAD -0.138 |
hsa-miR-23b-3p | MPV17 | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; OV; PAAD; PRAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.062; TCGA COAD -0.141; TCGA HNSC -0.091; TCGA KIRC -0.316; TCGA KIRP -0.145; TCGA LIHC -0.307; TCGA OV -0.068; TCGA PAAD -0.183; TCGA PRAD -0.136; TCGA SARC -0.063 |
hsa-miR-23b-3p | RPL19 | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; OV; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BRCA -0.15; TCGA COAD -0.172; TCGA HNSC -0.147; TCGA KIRC -0.292; TCGA KIRP -0.235; TCGA LGG -0.228; TCGA OV -0.156; TCGA PAAD -0.273; TCGA PRAD -0.336; TCGA STAD -0.14 |
hsa-miR-23b-3p | STK11IP | 10 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; STAD | miRNAWalker2 validate | TCGA BRCA -0.183; TCGA HNSC -0.068; TCGA KIRC -0.184; TCGA KIRP -0.128; TCGA LIHC -0.309; TCGA LUAD -0.106; TCGA LUSC -0.097; TCGA OV -0.088; TCGA PRAD -0.109; TCGA STAD -0.096 |
hsa-miR-23b-3p | PPIF | 12 cancers: BRCA; COAD; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.094; TCGA COAD -0.157; TCGA HNSC -0.412; TCGA KIRP -0.294; TCGA LGG -0.266; TCGA LUAD -0.236; TCGA PAAD -0.308; TCGA PRAD -0.21; TCGA SARC -0.215; TCGA THCA -0.352; TCGA STAD -0.336; TCGA UCEC -0.182 |
hsa-miR-23b-3p | TUSC2 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LUSC; OV; PRAD; UCEC | MirTarget | TCGA BRCA -0.192; TCGA COAD -0.126; TCGA ESCA -0.145; TCGA HNSC -0.085; TCGA KIRP -0.122; TCGA LUSC -0.087; TCGA OV -0.076; TCGA PRAD -0.168; TCGA UCEC -0.106 |
hsa-miR-23b-3p | VRK3 | 11 cancers: BRCA; CESC; ESCA; HNSC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.169; TCGA CESC -0.154; TCGA ESCA -0.285; TCGA HNSC -0.063; TCGA LUSC -0.115; TCGA OV -0.081; TCGA PRAD -0.063; TCGA SARC -0.127; TCGA THCA -0.135; TCGA STAD -0.232; TCGA UCEC -0.102 |
hsa-miR-23b-3p | CCNH | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.064; TCGA COAD -0.155; TCGA ESCA -0.176; TCGA HNSC -0.065; TCGA KIRC -0.068; TCGA KIRP -0.178; TCGA LGG -0.057; TCGA PAAD -0.122; TCGA PRAD -0.104; TCGA SARC -0.094; TCGA STAD -0.117 |
hsa-miR-23b-3p | MARCKSL1 | 12 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; OV; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.162; TCGA CESC -0.168; TCGA ESCA -0.637; TCGA HNSC -0.253; TCGA KIRC -0.17; TCGA LGG -0.13; TCGA LIHC -0.377; TCGA LUSC -0.337; TCGA OV -0.21; TCGA PRAD -0.521; TCGA STAD -0.474; TCGA UCEC -0.116 |
hsa-miR-23b-3p | ORMDL1 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BRCA -0.05; TCGA CESC -0.085; TCGA COAD -0.156; TCGA ESCA -0.175; TCGA KIRC -0.226; TCGA KIRP -0.136; TCGA LGG -0.138; TCGA LIHC -0.135; TCGA PRAD -0.218; TCGA SARC -0.056; TCGA STAD -0.16 |
hsa-miR-23b-3p | PTP4A2 | 12 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.088; TCGA CESC -0.161; TCGA ESCA -0.41; TCGA HNSC -0.083; TCGA KIRC -0.131; TCGA LIHC -0.114; TCGA LUAD -0.094; TCGA LUSC -0.126; TCGA SARC -0.125; TCGA THCA -0.072; TCGA STAD -0.191; TCGA UCEC -0.163 |
hsa-miR-23b-3p | OTUB1 | 9 cancers: BRCA; CESC; COAD; HNSC; KIRP; LUAD; OV; PAAD; PRAD | MirTarget; miRNATAP | TCGA BRCA -0.149; TCGA CESC -0.073; TCGA COAD -0.174; TCGA HNSC -0.242; TCGA KIRP -0.141; TCGA LUAD -0.088; TCGA OV -0.068; TCGA PAAD -0.207; TCGA PRAD -0.143 |
hsa-miR-23b-3p | ZNF138 | 16 cancers: BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.105; TCGA CESC -0.174; TCGA COAD -0.291; TCGA ESCA -0.277; TCGA KIRC -0.114; TCGA LGG -0.214; TCGA LIHC -0.214; TCGA LUAD -0.193; TCGA LUSC -0.172; TCGA OV -0.32; TCGA PAAD -0.282; TCGA PRAD -0.305; TCGA SARC -0.128; TCGA THCA -0.093; TCGA STAD -0.281; TCGA UCEC -0.213 |
hsa-miR-23b-3p | RPS19BP1 | 12 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BRCA -0.249; TCGA COAD -0.122; TCGA HNSC -0.151; TCGA KIRC -0.193; TCGA KIRP -0.12; TCGA LGG -0.075; TCGA LIHC -0.159; TCGA LUSC -0.109; TCGA PAAD -0.319; TCGA PRAD -0.231; TCGA SARC -0.125; TCGA UCEC -0.094 |
hsa-miR-23b-3p | GOLGA8B | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; PAAD; PRAD | MirTarget | TCGA BRCA -0.229; TCGA CESC -0.195; TCGA ESCA -0.28; TCGA HNSC -0.191; TCGA KIRC -0.835; TCGA LGG -0.44; TCGA LIHC -0.311; TCGA LUSC -0.504; TCGA PAAD -0.586; TCGA PRAD -0.343 |
hsa-miR-23b-3p | NDUFA2 | 9 cancers: BRCA; HNSC; KIRP; LGG; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.309; TCGA HNSC -0.113; TCGA KIRP -0.198; TCGA LGG -0.075; TCGA LUSC -0.101; TCGA PRAD -0.293; TCGA SARC -0.133; TCGA STAD -0.185; TCGA UCEC -0.132 |
hsa-miR-23b-3p | GBP3 | 9 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.147; TCGA CESC -0.186; TCGA ESCA -0.437; TCGA HNSC -0.23; TCGA LIHC -0.333; TCGA LUSC -0.258; TCGA SARC -0.24; TCGA STAD -0.471; TCGA UCEC -0.207 |
hsa-miR-23b-3p | COX16 | 9 cancers: BRCA; COAD; HNSC; LGG; LUSC; OV; PRAD; SARC; UCEC | MirTarget | TCGA BRCA -0.095; TCGA COAD -0.158; TCGA HNSC -0.196; TCGA LGG -0.14; TCGA LUSC -0.122; TCGA OV -0.147; TCGA PRAD -0.302; TCGA SARC -0.134; TCGA UCEC -0.134 |
hsa-miR-23b-3p | MOGS | 12 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.18; TCGA CESC -0.209; TCGA HNSC -0.119; TCGA KIRC -0.274; TCGA KIRP -0.154; TCGA LGG -0.124; TCGA LUAD -0.094; TCGA LUSC -0.1; TCGA PRAD -0.272; TCGA SARC -0.087; TCGA STAD -0.21; TCGA UCEC -0.121 |
hsa-miR-23b-3p | ZNF579 | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD | MirTarget | TCGA BRCA -0.347; TCGA CESC -0.336; TCGA HNSC -0.118; TCGA KIRC -0.378; TCGA KIRP -0.22; TCGA LGG -0.17; TCGA LUSC -0.296; TCGA PAAD -0.416; TCGA PRAD -0.199 |
hsa-miR-23b-3p | BET1 | 13 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.071; TCGA CESC -0.072; TCGA ESCA -0.247; TCGA HNSC -0.128; TCGA KIRC -0.275; TCGA KIRP -0.29; TCGA LUSC -0.183; TCGA OV -0.092; TCGA PRAD -0.145; TCGA SARC -0.121; TCGA THCA -0.057; TCGA STAD -0.209; TCGA UCEC -0.136 |
hsa-miR-23b-3p | QSOX1 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; SARC; UCEC | mirMAP | TCGA BRCA -0.19; TCGA CESC -0.312; TCGA ESCA -0.214; TCGA HNSC -0.134; TCGA KIRC -0.589; TCGA KIRP -0.353; TCGA LIHC -0.325; TCGA SARC -0.128; TCGA UCEC -0.294 |
hsa-miR-23b-3p | DUSP4 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; SARC | mirMAP | TCGA BRCA -0.401; TCGA CESC -0.802; TCGA ESCA -1.088; TCGA HNSC -0.376; TCGA KIRC -0.609; TCGA KIRP -0.676; TCGA LIHC -0.852; TCGA LUSC -0.659; TCGA SARC -0.339 |
hsa-miR-23b-3p | RPL37 | 10 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PAAD; PRAD; SARC | mirMAP | TCGA BRCA -0.128; TCGA HNSC -0.183; TCGA KIRC -0.448; TCGA KIRP -0.309; TCGA LGG -0.221; TCGA LUSC -0.143; TCGA OV -0.112; TCGA PAAD -0.427; TCGA PRAD -0.424; TCGA SARC -0.135 |
hsa-miR-23b-3p | PHKG2 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.241; TCGA HNSC -0.107; TCGA KIRC -0.143; TCGA KIRP -0.223; TCGA LUSC -0.129; TCGA PAAD -0.203; TCGA PRAD -0.166; TCGA STAD -0.142; TCGA UCEC -0.11 |
hsa-miR-23b-3p | SNX22 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; STAD | mirMAP; miRNATAP | TCGA BRCA -0.103; TCGA CESC -0.125; TCGA ESCA -0.282; TCGA HNSC -0.362; TCGA KIRC -0.386; TCGA LGG -0.367; TCGA LUSC -0.141; TCGA PAAD -0.43; TCGA PRAD -0.473; TCGA STAD -0.152 |
hsa-miR-23b-3p | EIF3F | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; OV; PAAD; PRAD | mirMAP | TCGA BRCA -0.069; TCGA CESC -0.097; TCGA HNSC -0.128; TCGA KIRC -0.161; TCGA KIRP -0.173; TCGA LGG -0.289; TCGA OV -0.091; TCGA PAAD -0.311; TCGA PRAD -0.194 |
hsa-miR-23b-3p | TMEM120B | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD | mirMAP; miRNATAP | TCGA BRCA -0.168; TCGA CESC -0.216; TCGA COAD -0.125; TCGA ESCA -0.211; TCGA HNSC -0.128; TCGA KIRC -0.167; TCGA LIHC -0.236; TCGA LUAD -0.141; TCGA LUSC -0.164; TCGA PAAD -0.325; TCGA PRAD -0.394 |
hsa-miR-23b-3p | NACC1 | 13 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.238; TCGA CESC -0.146; TCGA COAD -0.135; TCGA HNSC -0.113; TCGA KIRC -0.174; TCGA KIRP -0.276; TCGA LIHC -0.115; TCGA LUAD -0.166; TCGA PAAD -0.15; TCGA PRAD -0.175; TCGA SARC -0.077; TCGA STAD -0.115; TCGA UCEC -0.18 |
hsa-miR-23b-3p | SESN2 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.069; TCGA ESCA -0.183; TCGA HNSC -0.212; TCGA LGG -0.125; TCGA LUAD -0.11; TCGA LUSC -0.15; TCGA SARC -0.328; TCGA THCA -0.304; TCGA STAD -0.294; TCGA UCEC -0.163 |
hsa-miR-23b-3p | PFKFB4 | 10 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; UCEC | miRNATAP | TCGA BRCA -0.112; TCGA HNSC -0.265; TCGA KIRC -0.772; TCGA KIRP -0.357; TCGA LGG -0.129; TCGA LIHC -0.504; TCGA LUAD -0.372; TCGA LUSC -0.179; TCGA PRAD -0.201; TCGA UCEC -0.4 |
hsa-miR-23b-3p | HOXC4 | 9 cancers: BRCA; CESC; HNSC; LIHC; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA BRCA -0.099; TCGA CESC -0.451; TCGA HNSC -0.607; TCGA LIHC -0.717; TCGA LUSC -0.365; TCGA PAAD -0.366; TCGA PRAD -1.067; TCGA SARC -0.285; TCGA THCA -0.621 |
hsa-miR-23b-3p | PTBP1 | 9 cancers: BRCA; COAD; KIRC; LGG; LUAD; PAAD; PRAD; SARC; STAD | RAID | TCGA BRCA -0.082; TCGA COAD -0.147; TCGA KIRC -0.054; TCGA LGG -0.142; TCGA LUAD -0.098; TCGA PAAD -0.177; TCGA PRAD -0.163; TCGA SARC -0.084; TCGA STAD -0.178 |
hsa-miR-23b-3p | SUPT7L | 9 cancers: CESC; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PRAD | miRNAWalker2 validate | TCGA CESC -0.098; TCGA COAD -0.09; TCGA HNSC -0.101; TCGA KIRC -0.111; TCGA LGG -0.067; TCGA LIHC -0.063; TCGA LUAD -0.116; TCGA LUSC -0.144; TCGA PRAD -0.064 |
hsa-miR-23b-3p | NUP43 | 12 cancers: CESC; COAD; ESCA; KIRP; LGG; LIHC; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA CESC -0.101; TCGA COAD -0.195; TCGA ESCA -0.121; TCGA KIRP -0.075; TCGA LGG -0.183; TCGA LIHC -0.102; TCGA LUAD -0.127; TCGA OV -0.091; TCGA PAAD -0.174; TCGA PRAD -0.209; TCGA STAD -0.127; TCGA UCEC -0.118 |
hsa-miR-23b-3p | RCN1 | 12 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA CESC -0.223; TCGA ESCA -0.34; TCGA HNSC -0.217; TCGA KIRC -0.496; TCGA KIRP -0.408; TCGA LGG -0.164; TCGA LIHC -0.339; TCGA LUAD -0.124; TCGA LUSC -0.145; TCGA PRAD -0.138; TCGA THCA -0.24; TCGA STAD -0.244 |
hsa-miR-23b-3p | NUS1 | 10 cancers: CESC; COAD; ESCA; HNSC; LGG; LUAD; OV; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA CESC -0.089; TCGA COAD -0.218; TCGA ESCA -0.239; TCGA HNSC -0.096; TCGA LGG -0.06; TCGA LUAD -0.091; TCGA OV -0.1; TCGA PRAD -0.112; TCGA STAD -0.166; TCGA UCEC -0.103 |
hsa-miR-23b-3p | TOP1 | 12 cancers: CESC; COAD; ESCA; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA CESC -0.093; TCGA COAD -0.206; TCGA ESCA -0.429; TCGA LGG -0.087; TCGA LUAD -0.114; TCGA LUSC -0.139; TCGA OV -0.122; TCGA PRAD -0.108; TCGA SARC -0.105; TCGA THCA -0.139; TCGA STAD -0.297; TCGA UCEC -0.17 |
hsa-miR-23b-3p | APAF1 | 9 cancers: CESC; ESCA; KIRC; LUAD; LUSC; OV; SARC; THCA; STAD | miRNATAP | TCGA CESC -0.162; TCGA ESCA -0.541; TCGA KIRC -0.183; TCGA LUAD -0.109; TCGA LUSC -0.146; TCGA OV -0.104; TCGA SARC -0.12; TCGA THCA -0.083; TCGA STAD -0.269 |
hsa-miR-23b-3p | TMEM87B | 10 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA CESC -0.136; TCGA ESCA -0.315; TCGA HNSC -0.087; TCGA KIRC -0.2; TCGA KIRP -0.144; TCGA LIHC -0.105; TCGA PRAD -0.158; TCGA SARC -0.112; TCGA STAD -0.23; TCGA UCEC -0.073 |
hsa-miR-23b-3p | NPM1 | 12 cancers: COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA COAD -0.292; TCGA HNSC -0.186; TCGA KIRC -0.207; TCGA KIRP -0.221; TCGA LGG -0.213; TCGA LIHC -0.174; TCGA LUAD -0.12; TCGA LUSC -0.23; TCGA OV -0.137; TCGA PRAD -0.293; TCGA SARC -0.08; TCGA STAD -0.328 |
hsa-miR-23b-3p | RPS27A | 10 cancers: COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD | miRNAWalker2 validate | TCGA COAD -0.157; TCGA HNSC -0.165; TCGA KIRC -0.238; TCGA KIRP -0.223; TCGA LGG -0.229; TCGA LUAD -0.089; TCGA LUSC -0.125; TCGA OV -0.17; TCGA PAAD -0.247; TCGA PRAD -0.315 |
hsa-miR-23b-3p | SMN2 | 9 cancers: COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA COAD -0.211; TCGA HNSC -0.09; TCGA KIRC -0.229; TCGA KIRP -0.116; TCGA LGG -0.102; TCGA LUAD -0.093; TCGA LUSC -0.132; TCGA PRAD -0.154; TCGA STAD -0.299 |
hsa-miR-23b-3p | LTV1 | 10 cancers: COAD; ESCA; HNSC; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA COAD -0.227; TCGA ESCA -0.114; TCGA HNSC -0.075; TCGA LUAD -0.125; TCGA OV -0.181; TCGA PAAD -0.136; TCGA PRAD -0.138; TCGA SARC -0.204; TCGA STAD -0.142; TCGA UCEC -0.115 |
hsa-miR-23b-3p | UBE2D1 | 10 cancers: COAD; ESCA; HNSC; KIRC; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA COAD -0.148; TCGA ESCA -0.18; TCGA HNSC -0.132; TCGA KIRC -0.105; TCGA LUSC -0.22; TCGA OV -0.109; TCGA PRAD -0.154; TCGA SARC -0.103; TCGA THCA -0.074; TCGA UCEC -0.08 |
hsa-miR-23b-3p | NUP50 | 9 cancers: COAD; LGG; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA COAD -0.167; TCGA LGG -0.078; TCGA LIHC -0.091; TCGA LUAD -0.122; TCGA PRAD -0.106; TCGA SARC -0.114; TCGA THCA -0.147; TCGA STAD -0.244; TCGA UCEC -0.065 |
hsa-miR-23b-3p | DDX27 | 14 cancers: ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA ESCA -0.23; TCGA HNSC -0.153; TCGA KIRC -0.164; TCGA KIRP -0.112; TCGA LGG -0.07; TCGA LIHC -0.123; TCGA LUAD -0.122; TCGA LUSC -0.211; TCGA OV -0.054; TCGA PAAD -0.193; TCGA PRAD -0.109; TCGA SARC -0.075; TCGA STAD -0.141; TCGA UCEC -0.074 |
hsa-miR-23b-3p | TMEM167A | 9 cancers: ESCA; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA ESCA -0.135; TCGA LGG -0.059; TCGA LIHC -0.143; TCGA LUSC -0.096; TCGA PRAD -0.107; TCGA SARC -0.095; TCGA THCA -0.059; TCGA STAD -0.183; TCGA UCEC -0.106 |
hsa-miR-23b-3p | BLOC1S2 | 9 cancers: HNSC; KIRC; KIRP; LUAD; OV; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA HNSC -0.13; TCGA KIRC -0.18; TCGA KIRP -0.257; TCGA LUAD -0.075; TCGA OV -0.072; TCGA PRAD -0.198; TCGA SARC -0.222; TCGA STAD -0.148; TCGA UCEC -0.168 |
hsa-miR-23b-3p | NAP1L1 | 10 cancers: HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC | MirTarget; mirMAP; miRNATAP | TCGA HNSC -0.071; TCGA KIRC -0.318; TCGA KIRP -0.23; TCGA LGG -0.175; TCGA LIHC -0.187; TCGA LUAD -0.076; TCGA LUSC -0.117; TCGA OV -0.12; TCGA PRAD -0.236; TCGA SARC -0.091 |
hsa-miR-23b-3p | OTUB2 | 10 cancers: HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA HNSC -0.318; TCGA KIRP -0.14; TCGA LIHC -0.153; TCGA LUAD -0.133; TCGA LUSC -0.297; TCGA OV -0.154; TCGA PRAD -0.31; TCGA SARC -0.129; TCGA THCA -0.129; TCGA UCEC -0.136 |
Enriched cancer pathways of putative targets